YY 0329-2024Leukocyte reduction filters for single use (English PDF)
一次性使用去白细胞滤器
Open the YY 0329-2024 preview as PDF
This is a limited preview
Buy now to download the full PDF (23 pages)
Issued by
NMPA
Level / Type
Industry · Mandatory
Issue date
July 8, 2024
Implementation date
July 20, 2027
Scope
YY 0329-2024 is the English-translated version of 一次性使用去白细胞滤器.
YY 0329 is the mandatory standard for the single-use leukocyte reduction filter used in transfusion. Removing white cells from a blood component before it is transfused prevents febrile reactions, reduces HLA alloimmunisation and lowers the risk of transmitting cell-associated viruses, and universal leukoreduction is standard practice in most blood services. The filter's performance is expressed as the residual leukocyte count it achieves together with the recovery of the component that matters, red cells or platelets, since a filter that removes white cells by also removing the product is no use. The YY prefix without /T makes compliance compulsory in China. For a manufacturer or an importer of leukoreduction filters, this is the governing standard.
Document preview — YY 0329-2024
National Standard of the People's Republic of China
- ICS
- 11.040.20
- Classification
- C31
- Replacing
- YY 0329-2009
Issued by: National Medical Products Administration
Contents
- 1 Scope1
- 2 Normative references1
- 3 Terms and Definitions1
- 4 Classification and naming1
- 5 Materials1
- 6 Requirements and test methods1
- 6.1 Physical properties1
- 6.2 Chemical properties2
- 6.3 Biological properties3
- 6.4 Filtration performance3
- 7 Logo4
- 7.1 Primary packaging4
- 7.2 Outer packaging4
- 17 References19
Foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for standardization work Part
1.Structure and drafting rules for standardization documents" Drafting. This document replaces YY 0329-2009 "Disposable Leukocyte Removal Filter". Compared with YY 0329-2009, except for structural adjustments and In addition to editorial changes, the main technical changes are as follows:
--- Changed the tightness test conditions (see 6.1.2,
5.1.2 of the.2009 edition);
--- Changed the protective device (set) (see 6.1.6,
5.1.6 of the.2009 edition);
--- Changed biocompatibility (see 6.3.1,
5.5 of the.2009 edition);
--- Sterility has been changed (see 6.3.2,
5.3.1 of the.2009 edition);
--- Changes to bacterial endotoxins (see 6.3.3,
5.3.2 of the.2009 edition);
--- Changed the residual white blood cell count (see 6.4.1,
5.4.1 of the.2009 edition);
1 Scope
YY 0329 is the mandatory standard for the single-use leukocyte reduction filter used in transfusion. Removing white cells from a blood component before it is transfused prevents febrile reactions, reduces HLA alloimmunisation and lowers the risk of transmitting cell-associated viruses, and universal leukoreduction is standard practice in most blood services. The filter's performance is expressed as the residual leukocyte count it achieves together with the recovery of the component that matters, red cells or platelets, since a filter that removes white cells by also removing the product is no use. The YY prefix without /T makes compliance compulsory in China. For a manufacturer or an importer of leukoreduction filters, this is the governing standard.
This document specifies the classification and naming, materials, requirements, marking and packaging of single-use leukocyte removal filters and describes the corresponding tests. method. This document applies to single-use leukocyte removal filters (hereinafter referred to as "leukocyte removal filters").
Note. The leukocyte removal filter can be connected to a blood transfusion device, a blood collection/blood component separation system, and is used to remove leukocytes from blood and blood components.
2 Normative references
The contents of the following documents constitute essential clauses of this document through normative references in this document. For referenced documents without a date, only the version corresponding to that date applies to this document; for referenced documents without a date, the latest version (including all amendments) applies to This document.
GB/T 6682 Specifications and test methods for water used in analytical laboratories
GB 8369.1 Disposable blood transfusion sets Part
3 Terms and definitions
There are no terms or definitions that require definition in this document.
4 Classification and naming
Leukocyte-removal filters are divided into whole blood, red blood cell and platelet leukocyte-removal filters according to the blood components they filter. The leukocyte removal filter for whole blood and red blood cells that meets the requirements of this document is marked. RFYY 0329-2024. The leukocyte removal filter for platelets that meets the requirements of this document is marked. PFYY 0329-2024.
5 Materials
The materials used to manufacture leukocyte depletion filters shall meet the requirements of Chapter 6.
6.1 Physical properties
6.1.1 Appearance When tested with normal or corrected vision, the outer shell of the leukocyte removal filter should be smooth and free of obvious mechanical impurities, foreign matter, cracks, welding or adhesion.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 23 pages — is available in the English PDF.
Referenced standards
Normative references
- GB/T 6682Water for analytical laboratory use - Specification and test methods
- GB/T 14233.1-2022Test methods for infusion, transfusion, injection equipments for medical use - Part 1: Chemical analysis methods
- GB/T 14233.2Test methods for infusion, transfusion, injection equipment for medical use - Part 2: Biological test methods
- GB/T 16886.1Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
- YY/T 0466.1Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements
GB 8369.1 · YY/T 0615.1
Editions of YY 0329
| Edition | Title | Revision | Status |
|---|---|---|---|
| YY 0329-2024 | Leukocyte reduction filters for single use | current edition | Current |
| YY 0329-2009 | Leukocyte reduction filters for single use | previous edition | In force until 2027-07-20 |
This page sells the current edition, YY 0329-2024. Earlier editions are listed for reference only.
How to Buy YY 0329-2024
- 1Add to cart. Click the "Buy YY 0329-2024" button on this page. You can add more standards before checkout.
- 2Checkout. Enter your email and billing details. Payment is processed securely by Stripe (cards, Apple Pay, Google Pay supported).
- 3Instant delivery (0–9 sec). Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4Invoice included. A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 14233.1-2022 — Test methods for infusion, transfusion, injection equipments for medical use - Part 1: Chemical analysis methods
GB/T 14233.2-2025 — Test methods for infusion, transfusion, injection equipment for medical use - Part 2: Biological test methods
GB/T 16886.1-2022 — Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process
Secure payment via Stripe
Payments accepted
YY 0329-2024
$305.00